More reasons why olive leaves could help us
DOI:
https://doi.org/10.24310/enbio.v14i178.17047Keywords:
SARS-CoV-2, oliveAbstract
In a previous article, published in the 174th issue of Encuentros en la Biología, the three reasons why olive leaves could perhaps help us in the fight against SARS-CoV-2 are explained. Well, in parallel to the new knowledge that has been appearing around this virus, it is possible to hypothesize more ways in which olive leaves could help us.Downloads
References
Lee-Huang S y otros. Discovery of Small-Molecule HIV-1 Fusion and Integrase Inhibitors Oleuropein and Hydroxytyrosol: I. Fusion Inhibition. Biochem Biophys Res Commun. 2007 Mar 23; 354(4): 872–878. DOI: https://doi.org/10.1016/j.bbrc.2007.01.071
Ziyad Tariq Muhseen, Alaa R Hameed, Halah M H Al-Hasani y otros. Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach. J MolLiq. 2020 Diciembre 15;320:114493. DOI: https://doi.org/10.1016/j.molliq.2020.114493
Carino A, Moraca F, Fiorillo B, Marchianò S, y otros. Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain. Front Chem. 23 Oct 2020;8:572885. DOI: https://doi.org/10.3389/fchem.2020.572885
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma y otros. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J Biomol Struct Dyn. 2020 Jun 4;1-11. DOI: https://doi.org/10.21203/rs.3.rs-31210/v1
Khaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S, Soetjipto S. Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study. Preprints. Marzo 2020, 2020030226. DOI: https://doi.org/10.20944/preprints202003.0226.v1
Lama-Muñoz A, Contreras MDM, Espínola F, Moya M, Romero I, Castro E. Content of phenolic compounds and mannitol in olive leaves extracts from six Spanish cultivars: Extraction with the Soxhlet method and pressurized liquids. Food Chem. 2020 Agosto. 1;320:126626. DOI: https://doi.org/10.1016/j.foodchem.2020.126626
Magrone T, Spagnoletta A, Salvatore R, Magrone M y otros. Olive leaf extracts act as modulators of the human immune response. Endocr Metab Immune Disord Drug Targets. 2018;18(1):85-93. DOI: https://doi.org/10.2174/1871530317666171116110537
Filip Vlavcheski, Mariah Young and Evangelia Tsiani. Antidiabetic effects of Hydroxytyrosol: In vitro and In vivo evidence. Antioxidants (Basel). 2019 Jun; 8(6): 188. DOI: https://doi.org/10.3390/antiox8060188
José M. Santos-Lozano, Mirela Rada, José Lapetra y otros. Prevention of type 2 diabetes in prediabetic patients by using functional olive oil enriched in oleanolic acid: The PREDIABOLE study, a randomized controlled trial. Diabetes Obes Metab. 2019;21:2526–2534. DOI: https://doi.org/10.1111/dom.13838
Martin de Bock y otros. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: A randomized, placebo-controlled, crossover trial. PLoS One. 2013; 8(3): e57622. DOI: https://doi.org/10.1371/journal.pone.0057622
Valentini Konstantinidou y otros. Time course of changes in the expression of insulin sensitivity-related genes after an acute load of virgin olive oil. Omics: a Journal of Integrative Biology. May 2009. 13(5): 431-8. DOI: https://doi.org/10.1089/omi.2008.0085
Qiming Wang y otros. O-GlcNAC transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5. Science Advances. 15 Abril 2020. Vol. 6, no. 16. DOI: https://doi.org/10.1126/sciadv.aaz7086
Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020 Abril;162:108142. DOI: https://doi.org/10.1016/j.diabres.2020.108142
Qabaha K, Al-Rimawi F, Qasem A, Naser SA. Oleuropein is responsible for the major anti-inflammatory effects of olive leaf extract. J Med Food. 2018 Mar;21(3):302-305. DOI: https://doi.org/10.1089/jmf.2017.0070
Butler MJ y Barrientos RM. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav Immun. 2020 Jul;87:53-54. DOI: https://doi.org/10.1016/j.bbi.2020.04.040
Vezza T. y otros. The metabolic and vascular protective effects of olive (Olea europaea L. leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties. Pharmacol Res. Volume 150, Diciembre 2019. DOI: https://doi.org/10.1016/j.phrs.2019.104487
Kim YH, Choi YJ, Kang MK, Lee EJ, Kim DY, Oh H, Kang YH. Oleuropein curtails pulmonary inflammation and tissue destruction in models of experimental asthma and emphysema. J Agric Food Chem. 2018 Jul 25;66(29):7643-7654. DOI: https://doi.org/10.1021/acs.jafc.8b01808
Huguet-Casquero A, Moreno-Sastre M, López-Méndez TB, Gainza E, Pedraz JL. Encapsulation of oleuropein in nanostructured lipid carriers: Biocompatibility and antioxidant efficacy in lung epithelial cells. Pharmaceutics. 2020 May 6;12(5). DOI: https://doi.org/10.3390/pharmaceutics12050429
Kaeidi A, Sahamsizadeh A, Allahtavakoli M y otros. The effect of oleuropein on unilateral ureteral obstruction induced kidney injury in rats: the role of oxidative stress, inflammation and apoptosis. Mol Biol Rep. 2020 Feb;47(2):1371-1379. DOI: https://doi.org/10.1007/s11033-019-05237-0
Mahmoudi A, Hadrich F, Feki I, Ghorbel H y otros. Oleuropein and hydroxytyrosol rich extracts from olive leaves attenuate liver injury and lipid metabolism disturbance in bisphenol A-treated rats. Food Funct. 2018 Jun 20;9(6):3220- 3234. DOI: https://doi.org/10.1039/C8FO00248G
Theoharides TC, Stewart JM, Hatziagelaki E, Kolaitis G. Brain "fog,ïnflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Front Neurosci. 2015, Jul 3;9:225. DOI: https://doi.org/10.3389/fnins.2015.00225
Sarbishegi M, Charkhat Gorgich EA, Khajavi O, Komeili G, Salimi S. The neuroprotective effects of hydroalcoholic extract of olive (Olea europaea L.) leaf on rotenoneinduced Parkinson’s disease in rat. Metab Brain Dis. 2018 Feb;33(1):79-88. DOI: https://doi.org/10.1007/s11011-017-0131-0
Takaoka A, Yanai H. Interferon signalling network in innate defence. Cellular microbiology 2006, 8:907–922. DOI: https://doi.org/10.1111/j.1462-5822.2006.00716.x
Schroder K, Hertzoq PJ, Ravasi T, Hume DA. Interferon gamma: an overview of signals, mechanisms and functions. J.Leukoc Biol 2004, 75(2):163-189. DOI: https://doi.org/10.1189/jlb.0603252
Platanias LC. Mechanisms of type-I- and type-II-interferon mediated signalling. Nature reviews Immunology 2005; 5:375–386. DOI: https://doi.org/10.1038/nri1604
Randall RE, Goodbourn S. Interferons and viruses: an inter play between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008; 89 (Pt 1): 1-47. DOI: https://doi.org/10.1099/vir.0.83391-0
Kindler E, Thiel V, Weber F. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv Virus Res. 2016;96:219-243. DOI: https://doi.org/10.1016/bs.aivir.2016.08.006
Tommy R Tong. Therapies for coronaviruses. Part 2: inhibitors of intracellular life cycle. Expert Opinion on Therapeutic Patents. May 2009; 19(4):415-3. DOI: https://doi.org/10.1517/13543770802600698
Yu Y, Wang L, inventors. Artificial CpG single-stranded oligodeoxynucleotide and antiviral use thereof. Patent US20070155683; 2007.
Barnard D, Day C, Wandersee M y otros. Evaluation of interferon inducers, Ribavirin and mouse hyperimmune serum in a pathogenesis/lethal mouse model using a mouse-adapted SARS-CoV. Antiviral Res 2008; 78 (2): A20-A. DOI: https://doi.org/10.1016/j.antiviral.2008.01.025
Tan EL, Ooi EE, Lin CY y otros. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis 2004; 10 (4): 581 -6. DOI: https://doi.org/10.3201/eid1004.030458
Cinatl J, Morgenstern B, Bauer G y otros. Treatment of SARS with human interferons. Lancet 2003; 362 (9380): 293 -4. DOI: https://doi.org/10.1016/S0140-6736(03)13973-6
Jiancheng Zhang, Bing Xie y Kenji Hashimotoa. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav Immun. 2020 Jul;87:59-73. DOI: https://doi.org/10.1016/j.bbi.2020.04.046
Melika Lotfi, Michael R Hamblin y Nima Rezaei. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Review Clin Chim Acta. 2020 Sep;508:254-266. DOI: https://doi.org/10.1016/j.cca.2020.05.044
Ruth Williams. Discovered: Metabolic Mechanism of Cytokine Storms. The Scientist. Apr 15, 2020.
Khalatbary AR, Zarrinjoei GR. Anti-inflammatory effect of oleuropein in experimental rat spinal cord trauma. Iran. Red Crescent Med. J. 2012, 14, 229–234.
Saibandith B, Spencer JPE, Rowland IR, Commane DM. Olive polyphenols and the Metabolic Syndrome. Molecules. 2017 Jun 29;22(7). DOI: https://doi.org/10.3390/molecules22071082
Tuttolomondo A, Simonetta I, Daidone M, Mogavero A, Ortello A, Pinto A. Metabolic and vascular effect of the Mediterranean diet. Int J Mol Sci. 2019 Sep 23;20(19). DOI: https://doi.org/10.3390/ijms20194716
Cheng H, Wang Y, Wang GQ. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol. 2020 Jul;92(7):726-730. DOI: https://doi.org/10.1002/jmv.25785
Jefe A, Kao CH, PM de Murray, Marlow G, MP de Barnett, Ferguson LR. Estudio de intervención humana para evaluar los efectos de la suplementación con extracto de hoja de olivo en la expresión génica de células mononucleares de sangre periférica. Int J Mol Sci. 2016;17 (12).
?abarkapa A, Živkovi? L, Borozan S, Zlatkovi?-Švenda M, Dekanski D, Jan?i? I et al. Dry Olive Leaf Extract in Combination with Methotrexate Reduces Cell Damage in Early Rheumatoid Arthritis Patients-A Pilot Study. Phytother Res. 2016;30(10):1615-1623. DOI: https://doi.org/10.1002/ptr.5662
Lockyer S, Corona G, Yaqoob P, Spencer J, Rowland I. Secoiridoids delivered as olive leaf extract induce acute improvements in human vascular function and reduction of an inflammatory cytokine: a randomised, double-blind, placebo controlled, cross-over trial. Br J Nutr. 2015;114(1):75-83. DOI: https://doi.org/10.1017/S0007114515001269
Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020 Jul;39(7):2085-2094. DOI: https://doi.org/10.1007/s10067-020-05190-5
Downloads
Published
Dimensions
Issue
Section
License
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0.
Esta revista provee acceso libre inmediato a su contenido bajo el principio de hacer disponible gratuitamente la investigación al público. Todos los contenidos publicados en Encuentros en la Bilogía están sujetos a la licencia Creative Commons Reconocimento-NoComercia-Compartirigual 4.0 cuyo texto completo puede consultar en <http://creativecommons.org/licenses/by-nc-sa/4.0>
Se pueden copiar, usar, difundir, transmitir y exponer públicamente, siempre que:
Se cite la autoría y la fuente original de su publicación (revista, editorial y URL de la obra).
No se usen para fines comerciales.
Se mencione la existencia y especificaciones de esta licencia de uso
Los derechos de autor son de dos clases: morales y patrimoniales. Los derechos morales son prerrogativas perpetuas, irrenunciables, intransferibles, inalienables, inembargables e imprescriptibles. De acuerdo con la legislación de derechos de autor, Encuentros en la Biología reconoce y respeta el derecho moral de los autores/as, así como la titularidad del derecho patrimonial, el cual será cedido a la Universidad de Málaga para su difusión en acceso abierto. Los derechos patrimoniales, se refieren a los beneficios que se obtienen por el uso o divulgación de las obras. Encuentros en la Biología se publica en open access y queda autorizada en exclusiva para realizar o autorizar por cualquier medio el uso, distribución, divulgación, reproducción, adaptación, traducción o transformación de la obra.
Es responsabilidad de los autores/as obtener los permisos necesarios de las imágenes que están sujetas a derechos de autor.
Los autores/as cuyas contribuciones sean aceptadas para su publicación en esta revista conservarán el derecho no exclusivo de utilizar sus contribuciones con fines académicos, de investigación y educativos, incluyendo el auto-archivo o depósito en repositorios de acceso abierto de cualquier tipo.
La edición electrónica de esta revista esta editada por la Editorial de la Universidad de Málaga (UmaEditorial), siendo necesario citar la procedencia en cualquier reproducción parcial o total.
How to Cite
